Search

You searched for "elective"

2025 results found

Marsha de Cordova MP presented with an Honorary Fellowship of The College of Optometrists

6 February 2026 | optometry
This week, The College of Optometrists formally presented Marsha de Cordova MP with an Honorary Fellowship at the College’s headquarters in London. Marsha de Cordova is the Labour MP for Battersea, a former Lambeth Councillor and a longstanding champion of...

Early vitrectomy for endophthalmitis offers hope to patients

4 August 2026 | research, treatment
A Phase 2 feasibility study published today in the prestigious Nature Communications Medicine journal has shown that early vitrectomy surgery treatment for acute endophthalmitis can be potentially more beneficial to patients’ vision compared with the current antibiotic-first approach. This is...

New Moorfields stem cell treatment improves vision for untreatable condition

9 September 2026 | research, treatment
A new breakthrough stem cell treatment for ARK (aniridia-related keratopathy) has seen patients’ vision improve for this previously untreatable rare genetic eye condition in a first-in-human clinical trial at Moorfields Eye Hospital and the UCL Institute of Ophthalmology, published in...

Trends in Ophthalmology 2026

26 March 2026 -27 March 2026
51st Trends in Ophthalmology meeting

ANZGS Congress 2025

14 February 2025 -16 February 2025
As Chair of the Australian and New Zealand Glaucoma Society I am pleased to invite you to the 2025 ANZGS Congress which will be held in Perth from 14 – 16 February 2025. Following the triumph of the well-attended 2024...

27th Nottingham Eye Symposium and Research Meeting

24 January 2025
A unique opportunity for the dissemination and discussion of cutting-edge basic science and clinical ophthalmic research. Conference Chair: Ms. Dalia Said The 27th Nottingham Eye Symposium & Research Meeting anticipates a delegation of approx. 150 ophthalmologists from around the UK...

PACK-crosslinking for infectious keratitis

1 October 2015 | | EYE - Cornea
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...

Traumatic optic neuropathy

1 October 2021 | | EYE - Orbit, EYE - Neuro-ophthalmology, EYE - General
In neuro-ophthalmology we get asked a lot about management of patients who suffered significant trauma and presented with loss of vision secondary to presumed traumatic optic neuropathy (TON). TON happens usually in the context of significant craniofacial trauma. The incidence...

The ghost of Christmas present

1 December 2022 | | EYE - General
“Ah, youth is wasted on the wrong people.” Some will recognise this as one of the many brilliant quotes from what is considered to be the best Christmas movie ever – Frank Capra’s tear-jerker It’s a Wonderful Life (1946), although...

Pharma chameleon

3 April 2024 | | EYE - General
One morning in September ’95, about a month into my first house job on the South Coast of England, I emerged from the ridiculously early ward round on the coronary care unit feeling a bit dazed and therefore headed off...

GREG: An Introduction to Diabetic Retinopathy Grading

4 June 2026 -5 June 2026
Gloucestershire Research & Education Group An Introduction to Diabetic Retinopathy (DR) Grading

GREG (Gloucestershire Research & Education Group): Introduction to Grading Diabetic Retinopathy (DR)

11 November 2024 -12 November 2024
This course has been designed to introduce students to grading in diabetic retinopathy, based around national standards. It consists of pre-course online learning, and two days of face to face training. It explores diabetic retinopathy in depth, and provides students with an extensive understanding of how this condition is classified. The teaching is provided by Gloucestershire Research & Education Group and participants will receive an in-house certificate from the Gloucestershire Research & Education Group, on successful completion.